Q2 2016 Holdings
Filed 2016-08-15 | 27 holdings | $14.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $7.9M | 187,500 | 54.7% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $4.0M | 72,500 | 28.0% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $2.4M | 234,179 | 16.7% |
| Spark Therapeutics Inc | COM | 84652J103 | $8.3K | 162,500 | 0.1% |
| Foundation Medicine Inc | COM | 350465100 | $7.3K | 390,000 | 0.1% |
| Global Blood Therapeutics in | COM | 37890U108 | $7.1K | 430,000 | 0.0% |
| Loxo Oncology Inc | COM | 548862101 | $7.0K | 300,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $6.9K | 340,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $6.9K | 228,500 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $5.3K | 122,500 | 0.0% |
| Evolent Health Inc(EVH) | CL A | 30050B101 | $4.6K | 239,500 | 0.0% |
| Kite Pharma Inc | COM | 49803L109 | $3.6K | 72,500 | 0.0% |
| Genmark Diagnostics Inc(GNMK) | COM | 372309104 | $3.6K | 415,000 | 0.0% |
| Voyager Therapeutics Inc(VYGR) | COM | 92915B106 | $3.5K | 322,500 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $3.5K | 340,000 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $2.2K | 179,029 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $2.1K | 150,000 | 0.0% |
| Ignyta Inc | COM | 451731103 | $2.0K | 375,000 | 0.0% |
| Sage Therapeutics Inc(SG7)Call | COM | 78667J108 | $2.0K | 65,000 | 0.0% |
| Avexis Inc | COM | 05366U100 | $1.7K | 45,000 | 0.0% |
| Tesaro Inc | COM | 881569107 | $1.7K | 20,000 | 0.0% |
| Spdr Series Trust(XBI)Put | S&P BIOTECH | 78464A870 | $1.6K | 30,000 | 0.0% |
| Bristol Myers Squibb Co(BMY) | COM | 110122108 | $1.5K | 21,000 | 0.0% |
| Dexcom Inc(DXCM)Put | COM | 252131107 | $1.2K | 15,000 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $1.2K | 15,000 | 0.0% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $908 | 50,000 | 0.0% |
| Medgenics Inc | COM NEW | 58436Q203 | $472 | 85,000 | 0.0% |